Notably, lung function is impaired in comorbidities linked to increased risk of severe COVID-19 including obesity and type 2 diabetes [27–29]; furthermore, most cardio-metabolic comorbidities have been linked to increased expression of the angiotensin converting enzyme (ACE) [30, 31]. The gene discussed is ACE; the disease is obesity disorder.